Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno François, Robin Jeannet, Thomas Daix, et al.
JCI Insight (2018) Vol. 3, Iss. 5
Open Access | Times Cited: 325

Showing 1-25 of 325 citing articles:

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 652
The immunology of sepsis
Tom van der Poll, Manu Shankar‐Hari, W. Joost Wiersinga
Immunity (2021) Vol. 54, Iss. 11, pp. 2450-2464
Open Access | Times Cited: 534
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Di Liu, Siyuan Huang, Jianhui Sun, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 334
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
Kenneth E. Remy, Monty B. Mazer, David A. Striker, et al.
JCI Insight (2020) Vol. 5, Iss. 17
Open Access | Times Cited: 297
Flip the coin: IL-7 and IL-7R in health and disease
João T. Barata, Scott K. Durum, Benedict Seddon
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1584-1593
Open Access | Times Cited: 277
Current gaps in sepsis immunology: new opportunities for translational research
Ignacio Rubio, Marcin F. Osuchowski, Manu Shankar‐Hari, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 12, pp. e422-e436
Open Access | Times Cited: 274
Sepsis—Pathophysiology and Therapeutic Concepts
Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 253
Sepsis: Inflammation Is a Necessary Evil
Christina Nedeva, Joseph Menassa, Hamsa Puthalakath
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 248
Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
Jean‐Marc Cavaillon, Mervyn Singer, Tomasz Skirecki
EMBO Molecular Medicine (2020) Vol. 12, Iss. 4
Open Access | Times Cited: 231
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 11, pp. 3196-3207
Open Access | Times Cited: 227
Sepsis-Induced Immunosuppression
Lisa K. Torres, Peter Pickkers, Tom van der Poll
Annual Review of Physiology (2021) Vol. 84, Iss. 1, pp. 157-181
Open Access | Times Cited: 207
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
Mark S. Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 197
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*
Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Critical Care Medicine (2019) Vol. 47, Iss. 5, pp. 632-642
Open Access | Times Cited: 192
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome
Sophie Hüe, Asma Beldi‐Ferchiou, Inès Bendib, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 202, Iss. 11, pp. 1509-1519
Open Access | Times Cited: 188
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
José Laerte Boechat, Inês Chora, António Morais, et al.
Pulmonology (2021) Vol. 27, Iss. 5, pp. 423-437
Open Access | Times Cited: 186
Signaling pathways and intervention therapies in sepsis
Yunyu Zhang, Botao Ning
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 182
Extracorporeal Blood Purification Therapies for Sepsis
Céline Monard, Thomas Rimmelé, Claudio Ronco
Blood Purification (2019) Vol. 47, Iss. Suppl. 3, pp. 2-15
Open Access | Times Cited: 162
Immunotherapies for COVID-19: lessons learned from sepsis
Kenneth E. Remy, Scott C. Brakenridge, Bruno François, et al.
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 10, pp. 946-949
Open Access | Times Cited: 151
Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis
Christina Nedeva
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1011-1011
Open Access | Times Cited: 142
Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis
Deng Chen, Ting-Xuan Tang, Hai Deng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 135
COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 94
The pathophysiology of sepsis and precision-medicine-based immunotherapy
Evangelos J. Giamarellos‐Bourboulis, Anna C. Aschenbrenner, Michael Bauer, et al.
Nature Immunology (2024) Vol. 25, Iss. 1, pp. 19-28
Closed Access | Times Cited: 89
Immune dysregulation in sepsis: experiences, lessons and perspectives
Min Cao, Guozheng Wang, Jianfeng Xie
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
Sara Cajander, Matthijs Kox, Brendon P. Scicluna, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 4, pp. 305-322
Open Access | Times Cited: 49
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top